Millennium/Takeda’s Phase III IBD Drug Promises Improved Safety
Trials in Crohn’s disease and ulcerative colitis are going with plans for filing in both indications. Meanwhile, Takeda’s blockbuster GI drug Prevacid goes generic in May.
Trials in Crohn’s disease and ulcerative colitis are going with plans for filing in both indications. Meanwhile, Takeda’s blockbuster GI drug Prevacid goes generic in May.